milrinone and N-(1,3-benzodioxol-5-ylmethyl)-6-chloro-4-quinazolinamine

milrinone has been researched along with N-(1,3-benzodioxol-5-ylmethyl)-6-chloro-4-quinazolinamine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adachi, H; Saeki, T; Saito, I; Souda, S; Takase, Y; Watanabe, N	1

Other Studies

1 other study(ies) available for milrinone and N-(1,3-benzodioxol-5-ylmethyl)-6-chloro-4-quinazolinamine

Article	Year
Cyclic GMP phosphodiesterase inhibitors. 2. Requirement of 6-substitution of quinazoline derivatives for potent and selective inhibitory activity. Journal of medicinal chemistry, 1994, Jun-24, Volume: 37, Issue:13 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Aorta; Coronary Vessels; Cyclic AMP; Cyclic GMP; In Vitro Techniques; Muscle, Smooth, Vascular; Quinazolines; Spectrometry, Fluorescence; Structure-Activity Relationship; Swine; Vasodilation	1994

Article

Year

Cyclic GMP phosphodiesterase inhibitors. 2. Requirement of 6-substitution of quinazoline derivatives for potent and selective inhibitory activity.

Journal of medicinal chemistry, 1994, Jun-24, Volume: 37, Issue:13

Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Aorta; Coronary Vessels; Cyclic AMP; Cyclic GMP; In Vitro Techniques; Muscle, Smooth, Vascular; Quinazolines; Spectrometry, Fluorescence; Structure-Activity Relationship; Swine; Vasodilation

1994